Diagnos Inc Market Cap ($24.68 Million)
Market Cap & Net Worth: Diagnos Inc (ADK)
Diagnos Inc market cap. Diagnos Inc (V:ADK) has a market capitalization of $24.68 Million (CA$34.12 Million) as of November 1, 2026. Listed on the V stock exchange, this Canada-based company holds position #24288 globally and #905 in its home market, demonstrating a -12.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Diagnos Inc's stock price CA$0.34 by its total outstanding shares 101862977 (101.86 Million). Also see ADK cash generation efficiency for how efficiently the company converts equity into cash flow.
Diagnos Inc Market Cap History (2015–2026)
Diagnos Inc market cap history from 2015 to 2026. Data shows change from $33.16 Million to $24.68 Million (-2.64% CAGR). Check ADK stock price for real-time trading data and today's change.
Diagnos Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Diagnos Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ADK shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
269.76x
Diagnos Inc's market cap is 269.76 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $92.11 Million | $981.48K | -$3.19 Million | 93.85x | N/A |
| 2017 | $84.74 Million | $2.39 Million | -$5.42 Million | 35.45x | N/A |
| 2018 | $25.79 Million | $1.61 Million | -$2.90 Million | 15.99x | N/A |
| 2019 | $16.21 Million | $326.47K | -$3.84 Million | 49.66x | N/A |
| 2020 | $43.47 Million | $331.52K | -$3.38 Million | 131.14x | N/A |
| 2021 | $25.05 Million | $267.07K | -$2.05 Million | 93.81x | N/A |
| 2022 | $20.63 Million | $438.83K | -$2.61 Million | 47.02x | N/A |
| 2023 | $30.21 Million | $485.75K | -$2.48 Million | 62.20x | N/A |
| 2024 | $21.00 Million | $170.16K | -$3.12 Million | 123.42x | N/A |
| 2025 | $28.00 Million | $103.80K | -$4.29 Million | 269.76x | N/A |
Competitor Companies of ADK by Market Capitalization
Companies near Diagnos Inc in the global market cap rankings as of November 1, 2026. Also see Diagnos Inc assets under control for a full breakdown of the balance sheet.
Key companies related to Diagnos Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of Diagnos Inc (2015–2026)
Market capitalization of Diagnos Inc from 2015 to today. Between 2015 and today, Diagnos Inc's market cap moved from $33.16 Million to $ 24.68 Million, with a yearly change of -2.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$24.68 Million | -11.84% |
| 2025 | CA$28.00 Million | +33.33% |
| 2024 | CA$21.00 Million | -30.49% |
| 2023 | CA$30.21 Million | +46.43% |
| 2022 | CA$20.63 Million | -17.65% |
| 2021 | CA$25.05 Million | -42.37% |
| 2020 | CA$43.47 Million | +168.18% |
| 2019 | CA$16.21 Million | -37.14% |
| 2018 | CA$25.79 Million | -69.57% |
| 2017 | CA$84.74 Million | -8.00% |
| 2016 | CA$92.11 Million | +177.78% |
| 2015 | CA$33.16 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Diagnos Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.68 Million USD |
| MoneyControl | $24.68 Million USD |
| MarketWatch | $24.68 Million USD |
| marketcap.company | $24.68 Million USD |
| Reuters | $24.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Diagnos Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more